Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 12
972
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Does the rapid initiation of antiretroviral therapy at HIV diagnosis impact virological response in a real-life setting? A single-centre experience in Northern Italy

ORCID Icon, , ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 1938-1947 | Received 10 Jan 2022, Accepted 22 Jan 2023, Published online: 16 Feb 2023

References

  • Boyd, M. A., Boffito, M., Castagna, A., & Estrada, V. (2019). Rapid initiation of antiretroviral therapy at HIV diagnosis: Definition, process, knowledge gaps. HIV Medicine, 20(1), 3–11. https://doi.org/10.1111/hiv.12708
  • Cahn, P., Madero, J. S., Arribas, J. R., Antinori, A., Ortiz, R., Clarke, A. E., Hung, C.-C., Rockstroh, J. K., Girard, P.-M., Sievers, J., Man, C., Currie, A., Underwood, M., Tenorio, A. R., Pappa, K., Wynne, B., Fettiplace, A., Gartland, M., Aboud, M., … Perea, R. T. (2019). Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. The Lancet, 393(10167), 143–155. https://doi.org/10.1016/S0140-6736(18)32462-0
  • Caritas e Migrantes. (2019). XXVIII Rapporto Immigrazione 2018-2019. https://www.migrantes.it/wp-content/uploads/sites/50/2019/09/20190927-XXVIII-RICM-Presentazione.pdf
  • Coffey, S., Bacchetti, P., Sachdev, D., Bacon, O., Jones, D., Ospina-Norvell, C., Torres, S., Lynch, E., Camp, C., Mercer-Slomoff, R., Lee, S., Christopoulos, K., Pilcher, C., Hsu, L., Jin, C., Scheer, S., Havlir, D., & Gandhi, M. (2019). RAPID antiretroviral therapy: High virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS (London, England), 33(5), 825–832. https://doi.org/10.1097/QAD.0000000000002124
  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Cottle, L., Zhang, X. C., Makhema, J., … HPTN 052 Study Team (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. The New England Journal of Medicine, 375(9), 830–839. https://doi.org/10.1056/NEJMoa1600693
  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L.,   …   Khptn 052 Study Team (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. https://doi.org/10.1056/NEJMoa1105243
  • Comelli, A., Izzo, I., Donato, F., Celotti, A., Focà, E., Pezzoli, C., Castelli, F., & Quiros-Roldan, E. (2019). Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy. HIV Research & Clinical Practice, 20(1), 1–11. https://doi.org/10.1080/15284336.2019.1595887
  • Cuzin, L., Cotte, L., Delpierre, C., Allavena, C., Valantin, M. A., Rey, D., Delobel, P., Pugliese, P., Raffi, F., Cabié, A., & Dat’AIDS Study group (2019). Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohort. PloS one, 14(9), e0222067. https://doi.org/10.1371/journal.pone.0222067
  • D'Arminio Monforte, A., Tavelli, A., Cozzi-Lepri, A., Castagna, A., Passerini, S., Francisci, D., Saracino, A., Maggiolo, F., Lapadula, G., Girardi, E., Perno, C. F., Antinori, A., & Icona Foundation Study Group (2020). Virological response and retention in care according to time of starting ART in Italy: Data from the icona foundation study cohort. Journal of Antimicrobial Chemotherapy, 75(3), 681–689. https://doi.org/10.1093/jac/dkz512
  • EACS. (2020). EACS guidelines version 10.1. https://www.eacsociety.org/files/guidelines-10.1_finaljan2021_1.pdf
  • Fiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P., Schumacher, R., Peddada, L., Heldebrant, C., Smith, R., Conrad, A., Kleinman, S., & Busch, M. (2003). Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS (London, England), 17(13), 1871–1879. https://doi.org/10.1097/00002030-200309050-00005
  • Ford, N., Migone, C., Calmy, A., Kerschberger, B., Kanters, S., Nsanzimana, S., Mills, E. J., Meintjes, G., Vitoria, M., Doherty, M., & Shubber, Z. (2018). Benefits and risks of rapid initiation of antiretroviral therapy. AIDS (London, England), 32(1), 17–23. https://doi.org/10.1097/QAD.0000000000001671
  • Girometti, N., Nwokolo, N., McOwan, A., & Whitlock, G. (2017). Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation. Antiviral Therapy, 22(1), 77–80. https://doi.org/10.3851/IMP3080
  • Hoenigl, M., Chaillon, A., Moore, D. J., Morris, S. R., Mehta, S. R., Gianella, S., Amico, K. R., & Little, S. J. (2016). Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Scientific Reports, 6(1), 32947. https://doi.org/10.1038/srep32947
  • Huang, Y. C., Sun, H. Y., Chuang, Y. C., Huang, Y. S., Lin, K. Y., Huang, S. H., Chen, G. J., Luo, Y. Z., Wu, P. Y., Liu, W. C., Hung, C. C., & Chang, S. C. (2019). Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan. BMJ Open, 9(9), e033246. https://doi.org/10.1136/bmjopen-2019-033246
  • INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., Sharma, S., Avihingsanon, A., Cooper, D. A., Fätkenheuer, G., Llibre, J. M., Molina, J. M., Munderi, P., Schechter, M., Wood, R., Klingman, K. L., Collins, S., Lane, H. C., Phillips, A. N., & Neaton, J. D. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373(9), 795–807. https://doi.org/10.1056/NEJMoa1506816
  • Istituto Superiore di Sanità. (2020, November). Notiziario dell’Istituto Superiore di Sanità, 33(11). http://www.salute.gov.it/imgs/C_17_pubblicazioni_2979_allegato.pdf
  • Joint United Nations Programme on HIV/AIDS (UNAIDS). (2014). 90-90-90: An ambitious treatment target to help end the AIDS epidemic. https://www.unaids.org/en/resources/documents/2017/90-90-90
  • Koenig, S. P., Dorvil, N., Dévieux, J. G., Hedt-Gauthier, B. L., Riviere, C., Faustin, M., Lavoile, K., Perodin, C., Apollon, A., Duverger, L., McNairy, M. L., Hennessey, K. A., Souroutzidis, A., Cremieux, P. Y., Severe, P., & Pape, J. W. (2017). Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial. PLoS Medicine, 14(7), e1002357. https://doi.org/10.1371/journal.pmed.1002357
  • Labhardt, N. D., Ringera, I., Lejone, T. I., Klimkait, T., Muhairwe, J., Amstutz, A., & Glass, T. R. (2018). Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression Among adults With HIV in Lesotho: The CASCADE randomized clinical trial. JAMA, 319(11), 1103–1112. https://doi.org/10.1001/jama.2018.1818
  • Lapadula, G., Chatenoud, L., Gori, A., Castelli, F., Di Giambenedetto, S., Fabbiani, M., Maggiolo, F., Focà, E., Ladisa, N., Sighinolfi, L., Di Pietro, M., Pan, A., Torti, C., & Italian MASTER Cohort (2015). Risk of severe non AIDS events Is increased among patients unable to increase their CD4+ T-cell counts >200+/μl despite effective HAART. PloS one, 10(5), e0124741. https://doi.org/10.1371/journal.pone.0124741
  • Martin, T. C. S., Abrams, M., Anderson, C., & Little, S. J. (2021). Rapid antiretroviral therapy Among individuals With acute and early HIV. Clinical Infectious Diseases, 73(1), 130–133. https://doi.org/10.1093/cid/ciaa1174
  • Mateo-Urdiales, A., Johnson, S., Smith, R., Nachega, J. B., & Eshun-Wilson, I. (2019). Rapid initiation of antiretroviral therapy for people living with HIV. Cochrane Database of Systematic Reviews, 6(6), 18–19. https://doi.org/10.1002/14651858.CD012962.pub2
  • Montaner, J. S., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T., Shannon, K., Moore, D., Hogg, R. S., Barrios, R., Gilbert, M., Krajden, M., Gustafson, R., Daly, P., & Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV treatment as prevention” experience in a Canadian setting. PloS one, 9(2), e87872. https://doi.org/10.1371/journal.pone.0087872
  • Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council (OARAC). (2021). Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. U.S. Department of Health & Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
  • Pilcher, C. D., Ospina-Norvell, C., Dasgupta, A., Jones, D., Hartogensis, W., Torres, S., Calderon, F., Demicco, E., Geng, E., Gandhi, M., Havlir, D. V., & Hatano, H. (2017). The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting. Journal of Acquired Immune Deficiency Syndromes (1999), 74(1), 44–51. https://doi.org/10.1097/QAI.0000000000001134
  • Radix, A., & Shalev, N. (2021). When to Initiate Antiretroviral Therapy, With Protocol for Rapid Initiation. Johns Hopkins University. https://www.ncbi.nlm.nih.gov/books/NBK557123/
  • Rosen, S., Maskew, M., Fox, M. P., Nyoni, C., Mongwenyana, C., Malete, G., Sanne, I., Bokaba, D., Sauls, C., Rohr, J., & Long, L. (2016). Initiating antiretroviral therapy for HIV at a patient's first clinic visit: The RapIT randomized controlled trial. PLoS Medicine, 13(5), e1002015. https://doi.org/10.1371/journal.pmed.1002015
  • Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., Del Rio, C., Eron, J. J. J., Fätkenheuer, G., Günthard, H. F., Molina, J. M., Jacobsen, D. M., & Volberding, P. A. (2018). Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel. JAMA, 320(4), 379–396. https://doi.org/10.1001/jama.2018.8431
  • SIMIT. (2017). Linee guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2696_allegato.pdf
  • Thompson, M. A., Horberg, M. A., Agwu, A. L., Colasanti, J. A., Jain, M. A., Short, W. R., Singh, T., & Aberg, J. A. (2020). Primary care guidance for persons With human immunodeficiency virus: 2020 update by the HIV medicine association of the infectious diseases society of America. Clinical Infectious Diseases, 73(11), e3572–e3605. https://doi.org/10.1093/cid/ciaa1391
  • World Health Organization. (2017). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en/
  • World Health Organization. (2021). Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. https://www.who.int/publications/i/item/9789240022232